• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[一例不可切除的肝门部胆管癌对吉西他滨放化疗有效的病例]

[A case of unresectable hilar bile duct cancer responding to chemo-radiotherapy by gemcitabine].

作者信息

Kohya Naohiko, Hashiguchi Kazuyoshi, Yakabe Tomomi, Miyoshi Atsushi, Ohtsuka Takao, Kitahara Kenji, Miyazaki Kohji

机构信息

Dept. of Surgery, Saga University Faculty of Medicine.

出版信息

Gan To Kagaku Ryoho. 2009 Oct;36(10):1753-5.

PMID:19838042
Abstract

A 66-year-old woman was admitted to our hospital because of general fatigue and icterus. PTC findings showed irregular stenosis of hilar bile duct. Abdominal CT scan showed a dilatation of the intra-hepatic bile duct and a tumor around hilar bile duct. We diagnosed it as hilar bile duct carcinoma, and although we operated it was unresectable because of the metastasis of a para-aorta lymph node and duodenal invasion. We started chemo-radiotherapy with a total dose of 45 Gy and gemcitabine. The tumor and para-aorta lymph node were remarkably decreased, and tumor marker CA 19-9 was also decreased to within the normal range. The patient had a peritoneal dissemination 10 months after the chemo-radiotherapy and survived 20 months.

摘要

一名66岁女性因全身乏力和黄疸入住我院。经皮肝穿刺胆管造影(PTC)结果显示肝门部胆管不规则狭窄。腹部CT扫描显示肝内胆管扩张以及肝门部胆管周围有肿瘤。我们将其诊断为肝门部胆管癌,尽管进行了手术,但由于腹主动脉旁淋巴结转移和十二指肠侵犯,肿瘤无法切除。我们开始进行化疗放疗,总剂量为45 Gy,并使用吉西他滨。肿瘤和腹主动脉旁淋巴结明显缩小,肿瘤标志物CA 19-9也降至正常范围内。化疗放疗10个月后患者出现腹膜播散,存活了20个月。

相似文献

1
[A case of unresectable hilar bile duct cancer responding to chemo-radiotherapy by gemcitabine].[一例不可切除的肝门部胆管癌对吉西他滨放化疗有效的病例]
Gan To Kagaku Ryoho. 2009 Oct;36(10):1753-5.
2
[A Long-Term Survival Case of Unresectable Hilar Bile Duct Cancer Treated with Gemcitabine].[吉西他滨治疗不可切除性肝门部胆管癌的长期生存病例]
Gan To Kagaku Ryoho. 2015 Nov;42(11):1439-41.
3
[Long-term survival in 2 cases with unresectable hilar bile duct cancer and sclerosing cholangitis].[2例不可切除性肝门部胆管癌合并硬化性胆管炎患者的长期生存情况]
Gan To Kagaku Ryoho. 2012 Nov;39(12):2122-4.
4
[Long-term survivor of unresectable bile duct cancer complicated with sclerosing cholangitis treated with chemotherapy].[经化疗治疗的不可切除胆管癌合并硬化性胆管炎长期幸存者]
Gan To Kagaku Ryoho. 2014 Nov;41(12):1542-4.
5
Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience.吉西他滨联合立体定向体部放疗治疗不可切除的非转移性局部晚期肝门部胆管癌。5 年经验结果。
Radiother Oncol. 2011 May;99(2):120-3. doi: 10.1016/j.radonc.2011.05.016. Epub 2011 May 27.
6
[Long-surviving patient with hilar cholangiocarcinoma by gemcitabine monotherapy].[吉西他滨单药治疗肝门部胆管癌的长期存活患者]
Gan To Kagaku Ryoho. 2012 Nov;39(12):2116-8.
7
[Response in a case of inoperable bile duct cancer treated by combined chemotherapy of S-1 and gemcitabine].[S-1与吉西他滨联合化疗治疗不可切除胆管癌1例的疗效]
Gan To Kagaku Ryoho. 2010 Aug;37(8):1591-3.
8
Radiochemotherapy followed by gemcitabine and capecitabine in extrahepatic bile duct cancer: a phase I/II trial.肝外胆管癌中放化疗后使用吉西他滨和卡培他滨:一项I/II期试验
Am J Clin Oncol. 2006 Dec;29(6):576-82. doi: 10.1097/01.coc.0000239167.17922.82.
9
Repetitive response to gemcitabine that led to curative resection in cholangiocarcinoma.吉西他滨重复治疗反应致使胆管癌得以根治性切除。
World J Gastroenterol. 2009 Sep 28;15(36):4593-5. doi: 10.3748/wjg.15.4593.
10
[Unresectable combined hepatocellular-cholangiocellular carcinoma treated with transcatheter arterial chemoembolization and gemcitabine: a case study].[经肝动脉化疗栓塞术和吉西他滨治疗不可切除型肝细胞-胆管细胞癌:病例研究]
Nihon Shokakibyo Gakkai Zasshi. 2018;115(12):1069-1077. doi: 10.11405/nisshoshi.115.1069.